Managing drug discovery alliances for success

Research Technology Management

Volumn 48, Issue 5, 2005, Pages 42-50

  Laroia, Gaurav ^a   Krishnan, Shiv ^a  

^a SANOFI   (France)

Author keywords

Alliance management; Coordination and motivation; Drug discovery; S curve; Technology management

Indexed keywords

BIOTECHNOLOGY; INDUSTRIAL MANAGEMENT; MERGERS AND ACQUISITIONS; MOTIVATION;

ALLIANCE MANAGEMENT; COORDINATION AND MOTIVATION; DRUG DISCOVERY; S-CURVE; TECHNOLOGY MANAGEMENT;

DRUG PRODUCTS PLANTS;

EID: 33646422762     PISSN: 08956308     EISSN: None     Source Type: Journal    
DOI: 10.1080/08956308.2005.11657337     Document Type: Review

References (10)

1. Lam, Michael D. Dangerous Liaisons. Pharmaceutical Executive, May 2004, pp. 72-75.
2. Newbold, Ron. Innovation and Partnering at Merck. Reinventing Pharma and Biotech. Molecular Medicine Tri-Conference, San Francisco, California, March 24-26, 2004.
3. Would-be Oncology Giant. BioCentury "Ebb and Flow" section. March 22, 2004, Vol. 12, No. 13, p. A16.
4. Global Pharmaceutical Company Partnering Capabilities Survey. PriceWaterhouseCooper, 2000.
5. Milgrom, Paul and Roberts, John. Economics, Organization, & Management. Prentice Hall, 1992.
6. Foster, Richard N. The Attacker's Advantage. New York: Summit Books, 1986.
7. Utterback, James M. Mastering the Dynamics of Innovation, Boston: Harvard Business School Press, 1994.
8. Henderson, Rebecca. Eastman Kodak LFM Professor of Management, MIT Sloan School. http://www.mit.edu/people/rhenders/home.html
9. Hanrahan, Robert P. The IDEF Process Modeling Methodology. Software Technology Support Center. http://www.stsc.hill.af.mil/crosstalk/1995/06/idef. asp
10. Responsibility Charting (RACI). http://www.army.mil/aeioo/toolkits/ documents/tools/3/RACI_Approach.pdf